In contrast, both EGFR and its ligand, amphiregulin, markedly increased in ATMs in HFD-induced obesity, and selective deletion of EGFR in ATMs reduced HFD-induced obesity, adipose tissue derangements and insulin resistance. This evidence concerns the gene EGFR and obesity disorder.